ChemoMouthpiece, LLC (@CMPdevice) header
ChemoMouthpiece, LLC (@CMPdevice) profile picture

FDA 510(k) cleared oral cryotherapy device intended to cool the oral cavity to reduce the incidence and severity of chemotherapy induced oral mucositis.

Delaware
Joined February 2025
We had a great weekend connecting with oncology nurses at the Greater Tampa and Pinellas County Oncology Nursing Society (ONS) Annual Fall Conference, “Oncology Across the Spectrum,” at Moffitt Cancer Center! Special thanks to both ONS chapters for hosting this important event and to all the oncology nurses and healthcare professionals who stopped by our booth to learn more about the Chemo Mouthpiece oral cooling device and how it supports patients receiving chemotherapy. To learn more about the Chemo Mouthpiece and see Important Safety Information, visit: chemomouthpiece.com #Oncology #SupportiveCare #OncologyNursing #OralMucositis #CancerCare #ONS
19
We’re heading to #MEDICA2026 in Düsseldorf, Germany! 🇩🇪 From November 16–19, we’ll join the global healthcare community at MEDICA - Leading International Trade Fair, where innovations shaping the future of medical technology and patient care take center stage. Visit us at Hall 11 Stand #E89, to learn about the Chemo Mouthpiece®, an FDA 510(k) cleared oral cryotherapy device currently available in the United States. We’re eager to connect with potential European distribution partners as we continue to expand our international presence and prepare for the future introduction of the Chemo Mouthpiece to the EU. #MEDICA26 #Oncology #MedicalDevices #Düsseldorf #ChemoMouthpiece Intended Use (Rx Only): The Chemo Mouthpiece is intended to cool the oral mucosa to reduce the incidence and severity of chemotherapy induced oral mucositis in adult patients. Please see full Prescribing and Safety Information at ChemoMouthpiece.com.
1
21
Oral mucositis can affect nutrition, quality of life, and treatment adherence. For Kayla, the impact was deeply personal. Watch her story: chemomouthpiece.com/patient-… Actual patient. Individual experiences vary. #OralMucositis
8
Heading to #CFS26 in New York City this week? We're excited to attend the 44th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow™. Our team looks forward to connecting with the oncology community and sharing more about the Chemo Mouthpiece® medical device. FDA 510(k) cleared, the Chemo Mouthpiece is clinically proven to reduce the incidence and severity of chemotherapy induced oral mucositis in adult patients. Attending the conference? Connect with our team: November 11–13, 2026 at the New York Hilton Midtown, NYC Rx only. Please see Prescribing Information and Important Safety Information at ChemoMouthpiece.com #Oncology #SupportiveCare #CancerCare #CFS26 #OncologyConference
24
Our thanks to the Fort Worth Chapter of the Oncology Nursing Society (ONS) for welcoming our team at this week's vendor fair at the beautiful River Ranch in the Fort Worth Stockyards. 💙 We always appreciate the opportunity to connect with oncology nurses to discuss the clinical impact of oral mucositis and share how the Chemo Mouthpiece® oral cooling device helps support patients during chemotherapy treatment. We're grateful to be part of this dedicated oncology community. Learn more at ChemoMouthpiece.com #oralmucositis #chemomouthpiece #oncologynursing
15
Painful mouth sores during chemotherapy raised fears about Kayla's ability to continue treatment. In A Way Forward, she shares her experience during her second infusion. Watch her story: chemomouthpiece.com/patient-… Actual patient. Individual experiences vary. #OralMucositis
11
Oral mucositis can signiticantly affect patients during chemotherapy. In A Way Forward, Kayla shares her personal experience with this debilitating treatment-related complication. Watch her story: chemomouthpiece.com/patient-… #OralMucositis #SupportiveOncology
1
13
Our team is looking forward to attending the XXVII Brazilian Congress of Clinical Oncology in Rio de Janeiro, Brazil, November 5-7 alongside our partner Danialex Material Médico Hospitalar. Stop by Stand 36 to meet our team and learn about the Chemo Mouthpiece® medical device. FDA 510(k) cleared in the United States, the Chemo Mouthpiece is clinically proven to reduce the incidence and severity of chemotherapy induced oral mucositis in adult patients. Rx only. Please see U.S. Prescribing Information and Important Safety Information at ChemoMouthpiece.com #SBOC2026 #BrazilianOncology #SBOC
30
Oral mucositis (OM) remains one of the most clinically significant toxicities associated with many chemotherapy regimens. Severe OM can impair oral intake, increase infection risk, and necessitate opioid or analgesic management. In some cases, OM becomes a dose-limiting toxicity requiring treatment interruption, modification, or delay. Integrating OM education and proactive management strategies, such as oral cryotherapy, before treatment begins may help support treatment adherence and continuity of care throughout chemotherapy. Recent updates to the Oncology Nursing Society's (ONS) 2026 Mucositis guidance identify oral cryotherapy, including the use of oral cooling devices, as Recommended for Practice. Learn more at chemomouthpiece.com/hcp #OralMucositis #Oncology
12